Aeterna Zentaris Inc. (Nasdaq: AEZS) announced that final data for the Phase 1 portion of the ongoing Phase 1/2 trial ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE